Ann Alexis Prestrud
Overview
Explore the profile of Ann Alexis Prestrud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
989
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferreri D, Sutliffe J, Lopez N, Sutliffe C, Smith R, Carreras-Gallo N, et al.
Curr Dev Nutr
. 2024 Dec;
8(12):104497.
PMID: 39668946
Background: Plant-based diets are associated with lower inflammatory biomarkers and reduced risk of age-related chronic diseases. Epigenetic biomarkers of aging are DNA methylation-based tools that estimate biological age and rate...
2.
Smith M, Eggen M, Prestrud A, Lafferty-Danner K, Gyuras H, Bessett D, et al.
Perspect Sex Reprod Health
. 2024 Jul;
56(3):222-227.
PMID: 39031677
Objectives: Philanthropic abortion funds are integral to accessing care in the United States, providing both financial and practical assistance. Yet relatively little is known about those who seek these essential...
3.
Basch E, Prestrud A, Hesketh P, Kris M, Somerfield M, Lyman G
Am Soc Clin Oncol Educ Book
. 2014 Jan;
:532-40.
PMID: 24451791
In 2011, ASCO updated its guideline for the use of antiemetics in oncology, informed by a systematic review of the medical literature. This is an abbreviated version of that guideline,...
4.
Lyman G, Khorana A, Kuderer N, Prestrud A, Falanga A
J Clin Oncol
. 2013 Nov;
31(34):4381-2.
PMID: 24190116
No abstract available.
5.
Lyman G, Khorana A, Kuderer N, Lee A, Arcelus J, Balaban E, et al.
J Clin Oncol
. 2013 May;
31(17):2189-204.
PMID: 23669224
Purpose: To provide recommendations about prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer. Prophylaxis in the outpatient, inpatient, and perioperative settings was considered, as were treatment and...
6.
Loblaw D, Prestrud A, Somerfield M, Oliver T, Brouwers M, Nam R, et al.
J Clin Oncol
. 2012 Jul;
30(25):3136-40.
PMID: 22778311
The American Society of Clinical Oncology (ASCO) guidelines program employs a systematic review-based methodology to produce evidence-based guidelines. This is consistent with the stance of the Institute of Medicine on...
7.
Basch E, Hesketh P, Kris M, Prestrud A, Temin S, Lyman G
J Oncol Pract
. 2012 Mar;
7(6):395-8.
PMID: 22379425
ASCO's update to its antiemetics guideline now includes an evaluation of evidence on complementary antiemetic therapy.
8.
Basch E, Prestrud A, Hesketh P, Kris M, Feyer P, Somerfield M, et al.
J Clin Oncol
. 2011 Sep;
29(31):4189-98.
PMID: 21947834
Purpose: To update the American Society of Clinical Oncology (ASCO) guideline for antiemetics in oncology. Methods: A systematic review of the medical literature was completed to inform this update. MEDLINE,...
9.
Griggs J, Somerfield M, Anderson H, Henry N, Hudis C, Khatcheressian J, et al.
J Clin Oncol
. 2011 Sep;
29(29):3939-42.
PMID: 21900112
Purpose: The American Society of Clinical Oncology (ASCO) has policies and procedures for endorsing practice guidelines that have been developed by other professional organizations. Methods: The Cancer Care Ontario (CCO)...
10.
Burstein H, Prestrud A, Seidenfeld J, Anderson H, Buchholz T, Davidson N, et al.
J Clin Oncol
. 2010 Jul;
28(23):3784-96.
PMID: 20625130
Purpose: To develop evidence-based guidelines, based on a systematic review, for endocrine therapy for postmenopausal women with hormone receptor-positive breast cancer. Methods: A literature search identified relevant randomized trials. Databases...